Cargando…

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma

OBJECTIVE: Silent corticotroph adenomas (SCA) are endocrine-inactive pituitary adenomas with positive immunohistochemistry staining for adrenocorticotropic hormone (ACTH). We investigated whether SCA-associated clinical profiles were more aggressive than hormonally negative adenomas (HNA). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Junhyung, Yoon, Seon Jin, Moon, Ju Hyung, Ku, Cheol Ryong, Kim, Se Hoon, Lee, Eun Jig, Kim, Sun Ho, Kim, Eui Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurosurgical Society 2019
Materias:	Clinical Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328791/ https://www.ncbi.nlm.nih.gov/pubmed/30630298 http://dx.doi.org/10.3340/jkns.2018.0027

Ejemplares similares

Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma
por: Jung, Hyein, et al.
Publicado: (2021)

A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

LBODP079 A Case of Silent Invasive Corticotroph Adenoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2022)

Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience
por: Hong, Seung Woo, et al.
Publicado: (2021)

Surgical Treatment of Prolactinomas: Potential Role as a First-Line Treatment Modality
por: Kim, Eui Hyun, et al.
Publicado: (2023)

An Update on Silent Corticotroph Adenomas: Diagnosis, Mechanisms, Clinical Features, and Management
por: Jiang, Shenzhong, et al.
Publicado: (2021)

ODP312 Giant Silent Corticotroph Adenoma: Presentation of 3 Cases
por: Oliveira, Miriam C, et al.
Publicado: (2022)

Silent Crooke’s cell corticotroph adenoma of the pituitary gland presenting as delayed puberty
por: Giri, Dinesh, et al.
Publicado: (2017)

The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas
por: Andonegui-Elguera, Sergio, et al.
Publicado: (2022)

Effects of Oxytocin on Cell Proliferation in a Corticotroph Adenoma Cell Line
por: Lim, Jung Soo, et al.
Publicado: (2019)

Refractory corticotroph adenomas
por: Sumal, Amit K. S., et al.
Publicado: (2023)

Neurocysticercosis, Meningioma, and Silent Corticotroph Pituitary Adenoma in a 61-Year-Old Woman
por: Ramirez, Maria del Pilar, et al.
Publicado: (2012)

Postoperative expression of Cushing disease in a young male: metamorphosis of silent corticotroph adenoma?
por: Jahan, Sharmin, et al.
Publicado: (2019)

Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature
por: Pecorari, Isabella L., et al.
Publicado: (2022)

PMON122 Unveiling the Kraken- An Incidentally Found Silent Corticotroph Adenoma of the Pituitary Gland
por: Shteyman, Sara, et al.
Publicado: (2022)

A silent corticotroph adenoma: making the case for a pars intermedia origin. Illustrative case
por: Alsavaf, Mohammad Bilal, et al.
Publicado: (2023)

ODP351 Silent Corticotroph Adenomas – Characteristics and Comparisons to Other Non-functioning Pituitary Adenomas: A Case Series
por: Di Ieva, Antonio, et al.
Publicado: (2022)

Dexamethasone suppression for (18)F-FDG PET/CT to localize ACTH-secreting pituitary tumors
por: Kim, Kyungwon, et al.
Publicado: (2023)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant
por: Ku, Cheol Ryong, et al.
Publicado: (2021)

SAT-LB57 The Spectrum of Genomic and Transcriptomic Alterations in ACTH-Producing and ACTH-Silent Corticotroph Adenomas
por: Lerario, Antonio Marcondes, et al.
Publicado: (2020)

Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas
por: Kim, Jean, et al.
Publicado: (2020)

Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas
por: Eieland, Alexander K., et al.
Publicado: (2020)

SAT-436 Adjuvant Therapeutic Modalities in Acromegaly: Clinical Course and Factors Predicting Biochemical Controls
por: Jung, Hyein, et al.
Publicado: (2019)

New Transcriptional Insights into Silent and Active Corticotroph Pituitary Tumors at Single Cell Resolution
por: Zhang, Dongyun, et al.
Publicado: (2021)

Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
por: Kim, Daham, et al.
Publicado: (2019)

Quantitative Ubiquitinomics Revealed Abnormal Ubiquitinated ATP7A Involved in Down-Regulation of ACTH in Silent Corticotroph Adenomas
por: Zhao, Sida, et al.
Publicado: (2022)

Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors
por: García-Martínez, Araceli, et al.
Publicado: (2020)

MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR
por: Reyes-Vidal, Carlos, et al.
Publicado: (2020)

Difference in miRNA Expression in Functioning and Silent Corticotroph Pituitary Adenomas Indicates the Role of miRNA in the Regulation of Corticosteroid Receptors
por: Mossakowska, Beata J., et al.
Publicado: (2022)

MON-436 Clinical Phenotypes of GNAS Gene Mutations in Acromegalic Patients
por: Jung, Hyein, et al.
Publicado: (2019)

Silent Corticotroph Tumor with Adrenocortical Choristoma in an Eleven-year-old Boy
por: Turan, Hande, et al.
Publicado: (2022)

The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
por: Regazzo, Daniela, et al.
Publicado: (2022)

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
por: Kim, Kyungwon, et al.
Publicado: (2023)

No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study)
por: Ku, Cheol Ryong, et al.
Publicado: (2016)

Clinical, Laboratory, and Treatment Profiles of Silent Corticotroph Adenomas That Have Transformed to the Functional Type: A Case Series With a Literature Review
por: Zheng, Guangyao, et al.
Publicado: (2020)

MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal
por: Kim, Kyungwon, et al.
Publicado: (2019)

Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma
por: Kim, Hae-Kyung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrss3nhec8qqntr2gri039b4k4